Trials / Completed
CompletedNCT00942240
Safety and Tolerability of Repeat Doses of ACU-4429 in Healthy Subjects
A Phase I, Double-Masked, Multiple Rising Dose Study of ACU-4429 in Healthy Male and Female Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Kubota Vision Inc. · Industry
- Sex
- All
- Age
- 25 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety and tolerability of repeated doses of a new investigational drug (ACU-4429) in healthy human subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ACU-4429 | administered orally once a day for 14 days |
| DRUG | matching placebo tablet | administered orally once a day for 14 days |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2009-07-20
- Last updated
- 2012-01-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00942240. Inclusion in this directory is not an endorsement.